Hexagon Nutrition Limited
61.68
INR
-3.51
(-5.38%)
ISIN
INE0JUI01012
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Quarterly Revenue
INR
•
in mil. unless spec.Quarterly Earnings Per Share
INR
•
in mil. unless spec.Quarterly Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Nikhil Arun Kelkar
- Full Time Employees
- 527
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Mumbai India
- Website
- hexagonnutrition.com
- Similar Companies
- Business
- Hexagon Nutrition Limited is a research-oriented nutrition and healthcare company that specializes in the development, manufacturing, and marketing of clinical nutrition formulations, customized micronutrient premixes, and therapeutic foods. Founded in 1993 and headquartered in Mumbai, India, the company operates across three core business segments: Branded Clinical and Wellness Nutrition, Micronutrient Premixes, and Therapeutic/Institutional Foods. The company's product portfolio includes disease-specific and general clinical nutrition supplements formulated for oncology, renal care, diabetes management, hepatic health, and critical care under the PentaSure brand; pediatric nutrition products designed for growth and recovery under the PediaGold brand; meal replacement and weight management formulations under the ObesiGo brand; adult wellness supplements under the NutrOne brand; customized vitamin, mineral, and amino acid premixes engineered for fast-moving consumer goods (FMCG) and food processing companies to fortify staple goods such as flour, edible oils, rice, dairy, and infant foods; and specialized therapeutic formulations, including ready-to-use therapeutic food (RUTF), ready-to-use supplementary food (RUSF), and micronutrient powders (MNPs), delivered to public health programs and international humanitarian agencies to combat malnutrition. Hexagon Nutrition operates manufacturing facilities in Nashik, Chennai, and Thoothukudi in India, as well as an international facility in Tashkent, Uzbekistan. The company serves institutional healthcare networks, retail pharmacies, and consumer e-commerce channels in India, while exporting its products to over 75 countries across Asia, Africa, the Middle East, and the Commonwealth of Independent States (CIS). In recent developments, Hexagon Nutrition completed its initial public offering (IPO) and listed its equity shares on the National Stock Exchange of India (NSE: HEXAGON) and the BSE in June 2026. The company also expanded its technical manufacturing capabilities through a technology transfer partnership with French processing specialist LIS by Lesaffre, completing commercial-scale process validation for VIT A+, a high-stability vitamin A palmitate formulation designed for cost-effective food fortification in low- and middle-income countries. Additionally, the company continues to advance its global export expansion strategy to broaden the commercial distribution of its clinical nutrition brands and scale supply arrangements with international relief organizations.